The bill modifies the existing drug take-back program in Washington State by updating fee structures, enforcement regulations, and performance reporting requirements for program operators. Key changes include the introduction of a new reporting framework that requires program operators to submit detailed annual reports to the Department of Health, including information on collection amounts, public education efforts, and financial expenditures. The bill also mandates that the Department evaluate these reports for compliance and allows for penalties against non-compliant manufacturers and program operators. Additionally, a one-time fee of $70,000 will be imposed on approved program operators to fund an expedited review of the department's fee-setting authority.

Furthermore, the bill establishes a new section that tasks the Joint Legislative Audit and Review Committee with conducting an expedited review of the drug take-back program's fee-setting authority by December 31, 2025. This review will assess whether the fees cover the actual costs of administration and enforcement, ensuring transparency and appropriateness of expenditures. The bill also includes provisions for repealing certain sections of existing law by January 1, 2030, as part of the overall restructuring of the drug take-back program.

Statutes affected:
Original Bill: 69.48.100, 69.48.110, 69.48.120, 69.48.130, 43.131.424
Substitute Bill: 69.48.100, 69.48.110, 69.48.120, 69.48.130
Second Substitute: 69.48.100, 69.48.110, 69.48.120, 69.48.130
Engrossed Second Substitute: 69.48.100, 69.48.110, 69.48.120, 43.131.424
Bill as Passed Legislature: 69.48.100, 69.48.110, 69.48.120, 43.131.424
Session Law: 69.48.100, 69.48.110, 69.48.120, 43.131.424